FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324075785> ?p ?o ?g. }

• W4324075785 abstract "Osteosarcoma (OS) and Ewing sarcoma (ES) are the two most common types of primary bone cancer that predominantly affect the young. Despite aggressive multimodal treatment, survival has not improved significantly over the past four decades. Clinical efficacy has historically been observed for some mono-Receptor Tyrosine Kinase (RTK) inhibitors, albeit in small subsets of OS and ES patients. Clinical efficacy in larger groups of OS or ES patients was reported recently with several newer generation multi-RTK inhibitors. All these inhibitors combine a strong anti-angiogenic (VEGFRs) component with simultaneous inhibition of other key RTKs implicated in OS and ES progression (PDGFR, FGFR, KIT and/or MET). However, despite interesting clinical data, none of these agents have obtained a registration for these indications and are thus difficult to implement in routine OS and ES patient care. It is at present also unclear which of these drugs, with largely overlapping molecular inhibition profiles, would work best for which patient or subtype, and treatment resistance almost uniformly occurs. Here, we provide a critical assessment and systemic comparison on the clinical outcomes to the six most tested drugs in this field in OS and ES to date, including pazopanib, sorafenib, regorafenib, anlotinib, lenvatinib and cabozantinib. We pay special attention to clinical response evaluations in bone sarcomas and provide drug comparisons, including drug-related toxicity, to put these drugs into context for OS and ES patients, and describe how future trials utilizing anti-angiogenic multi-RTK targeted drugs could be designed to ultimately improve response rates and decrease toxicity." @default.
• W4324075785 created "2023-03-14" @default.
• W4324075785 creator A5004235393 @default.
• W4324075785 creator A5012955112 @default.
• W4324075785 creator A5055163903 @default.
• W4324075785 date "2023-03-13" @default.
• W4324075785 modified "2023-10-18" @default.
• W4324075785 title "Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma" @default.
• W4324075785 cites W1534235733 @default.
• W4324075785 cites W1540759505 @default.
• W4324075785 cites W1600368247 @default.
• W4324075785 cites W1645010355 @default.
• W4324075785 cites W1862034061 @default.
• W4324075785 cites W1879554030 @default.
• W4324075785 cites W1987711531 @default.
• W4324075785 cites W1993682120 @default.
• W4324075785 cites W1998120322 @default.
• W4324075785 cites W2036138031 @default.
• W4324075785 cites W2044313879 @default.
• W4324075785 cites W2051351379 @default.
• W4324075785 cites W2065973493 @default.
• W4324075785 cites W2101776780 @default.
• W4324075785 cites W2107600107 @default.
• W4324075785 cites W2116922255 @default.
• W4324075785 cites W2128486176 @default.
• W4324075785 cites W2142834543 @default.
• W4324075785 cites W2145088312 @default.
• W4324075785 cites W2152274262 @default.
• W4324075785 cites W2155000185 @default.
• W4324075785 cites W2167348613 @default.
• W4324075785 cites W2316750470 @default.
• W4324075785 cites W2415950182 @default.
• W4324075785 cites W2589508714 @default.
• W4324075785 cites W2604657682 @default.
• W4324075785 cites W2618004482 @default.
• W4324075785 cites W2697609317 @default.
• W4324075785 cites W2747989445 @default.
• W4324075785 cites W2770987316 @default.
• W4324075785 cites W2787358630 @default.
• W4324075785 cites W2802389749 @default.
• W4324075785 cites W2803924465 @default.
• W4324075785 cites W2885717915 @default.
• W4324075785 cites W2889673034 @default.
• W4324075785 cites W2890746729 @default.
• W4324075785 cites W2890763692 @default.
• W4324075785 cites W2891571211 @default.
• W4324075785 cites W2892650455 @default.
• W4324075785 cites W2897470314 @default.
• W4324075785 cites W2901259053 @default.
• W4324075785 cites W2903630948 @default.
• W4324075785 cites W2905567470 @default.
• W4324075785 cites W2913910566 @default.
• W4324075785 cites W2921652393 @default.
• W4324075785 cites W2941090871 @default.
• W4324075785 cites W2998558444 @default.
• W4324075785 cites W3006180429 @default.
• W4324075785 cites W3007595469 @default.
• W4324075785 cites W3008367353 @default.
• W4324075785 cites W3018854574 @default.
• W4324075785 cites W3021104551 @default.
• W4324075785 cites W3029605129 @default.
• W4324075785 cites W3029913779 @default.
• W4324075785 cites W3031082563 @default.
• W4324075785 cites W3031421866 @default.
• W4324075785 cites W3082201370 @default.
• W4324075785 cites W3089143851 @default.
• W4324075785 cites W3105258331 @default.
• W4324075785 cites W3132817859 @default.
• W4324075785 cites W3164260637 @default.
• W4324075785 cites W3168212396 @default.
• W4324075785 cites W3191201451 @default.
• W4324075785 cites W3195419801 @default.
• W4324075785 cites W3197355167 @default.
• W4324075785 cites W3214866947 @default.
• W4324075785 cites W4205899024 @default.
• W4324075785 cites W4211048667 @default.
• W4324075785 cites W4283710798 @default.
• W4324075785 cites W4292712479 @default.
• W4324075785 doi "https://doi.org/10.3389/fonc.2023.1013359" @default.
• W4324075785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36994209" @default.
• W4324075785 hasPublicationYear "2023" @default.
• W4324075785 type Work @default.
• W4324075785 citedByCount "1" @default.
• W4324075785 countsByYear W43240757852023 @default.
• W4324075785 crossrefType "journal-article" @default.
• W4324075785 hasAuthorship W4324075785A5004235393 @default.
• W4324075785 hasAuthorship W4324075785A5012955112 @default.
• W4324075785 hasAuthorship W4324075785A5055163903 @default.
• W4324075785 hasBestOaLocation W43240757851 @default.
• W4324075785 hasConcept C101544691 @default.
• W4324075785 hasConcept C121608353 @default.
• W4324075785 hasConcept C126322002 @default.
• W4324075785 hasConcept C142724271 @default.
• W4324075785 hasConcept C143998085 @default.
• W4324075785 hasConcept C151730666 @default.
• W4324075785 hasConcept C170493617 @default.
• W4324075785 hasConcept C2776248978 @default.
• W4324075785 hasConcept C2776264508 @default.
• W4324075785 hasConcept C2777760704 @default.
• W4324075785 hasConcept C2778019345 @default.

• next